Loading data
ZLABNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 457.18 m USD | 397.61 m USD | 266.72 m USD | 212.67 m USD | 144.11 m USD |
| Cost of revenue | 190.52 m USD | 147.12 m USD | 95.82 m USD | 74.02 m USD | 52.24 m USD |
| Research and development expense | 220.9 m USD | 234.5 m USD | 265.87 m USD | 286.41 m USD | 573.31 m USD |
| Selling, general and administrative expense | 277.61 m USD | 298.74 m USD | 281.61 m USD | 258.97 m USD | 218.83 m USD |
| Operating profit | -229.43 m USD | -282.12 m USD | -366.57 m USD | -404.36 m USD | -700.06 m USD |
| Interest expense | — | 2.25 m USD | 0 USD | 0 USD | 0 USD |
| Profit before tax | -178.46 m USD | -257.1 m USD | -334.62 m USD | -443.29 m USD | -704.47 m USD |
| Income tax expense | -2.93 m USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -175.5 m USD | -257.1 m USD | -334.6 m USD | -443.3 m USD | -704.5 m USD |
| Net income attributable to common shareholders | -175.54 m USD | -257.1 m USD | -334.62 m USD | -443.29 m USD | -704.47 m USD |
| Basic earnings per share | -0.16 USD/share | -0.26 USD/share | -0.35 USD/share | -0.46 USD/share | -0.76 USD/share |
| Diluted earnings per share | -0.16 USD/share | -0.26 USD/share | -0.35 USD/share | -0.46 USD/share | -0.76 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.